{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:27:59Z","timestamp":1793305679511,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s11894-021-00825-2","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T05:02:37Z","timestamp":1637730157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Newborn Screening for Biliary Atresia: a Review of Current Methods"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6307-4774","authenticated-orcid":false,"given":"Tebyan","family":"Rabbani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Guthery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Himes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Shneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv","family":"Harpavat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"issue":"3","key":"825_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/hep.29905","volume":"68","author":"JA Bezerra","year":"2018","unstructured":"Bezerra JA, Wells RG, Mack CL, et al. Biliary atresia: clinical and research challenges for the twenty-first century. Hepatology. 2018;68(3):1163\u201373. https:\/\/doi.org\/10.1002\/hep.29905.","journal-title":"Hepatology."},{"key":"825_CR2","doi-asserted-by":"crossref","unstructured":"Sokol RJ, Shepherd RW, Superina R, Bezerra JA, Robuck P, Hoofnagle JH. Screening and outcomes in biliary atresia: Summary of a national institutes of health workshop. In: Hepatology. Vol 46. Hepatology; 2007:566\u2013581. doi:10.1002\/hep.21790.","DOI":"10.1002\/hep.21790"},{"key":"825_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jpeds.2017.05.006","volume":"187","author":"PC Hopkins","year":"2017","unstructured":"Hopkins PC, Yazigi N, Nylund CM. Incidence of biliary atresia and timing of Hepatoportoenterostomy in the United States. J Pediatr. 2017;187:253\u20137. https:\/\/doi.org\/10.1016\/j.jpeds.2017.05.006.","journal-title":"J Pediatr"},{"key":"825_CR4","unstructured":"Wilson JMG JG. Principles and Practice of Screening for Disease. WHO Public Paper 34.; 1968. Accessed June 23, 2021. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/37650\/WHO_PHP_34.pdf."},{"key":"825_CR5","doi-asserted-by":"publisher","unstructured":"Mowat AP, Davidson LL, Dick MC. Earlier identification of biliary atresia and hepatobiliary disease: selective screening in the third week of life. Arch dis child. 1995;72(1):90-92. https:\/\/doi.org\/10.1136\/adc.72.1.90. Results from one of the earliest studies to screen infants that are jaundice with serum conjugated bilirubin measurements.","DOI":"10.1136\/adc.72.1.90"},{"issue":"1","key":"825_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1542\/peds.114.1.297","volume":"114","author":"S Hyperbilirubinemia","year":"2004","unstructured":"Hyperbilirubinemia S. On. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297\u2013316. https:\/\/doi.org\/10.1542\/peds.114.1.297.","journal-title":"Pediatrics."},{"key":"825_CR7","doi-asserted-by":"crossref","unstructured":"Bergman DA, Cooley JR, Coombs JB, et al. Practice parameter: Management of hyperbilirubinemia in the healthy term newborn. Pediatrics. 1994;94(4 I):558\u2013565.","DOI":"10.1542\/peds.94.4.558"},{"key":"825_CR8","doi-asserted-by":"crossref","unstructured":"Thomas K. McInerny, Henry M. Adam, Deborah E. Campbell JMF and DMK. AAP Textbook of Pediatric Care, 2nd Ed. (Deepak M. TKAMHMCDEFJMK, ed.). American Academy of Pediatrics; 2016. https:\/\/ebooks.aappublications.org\/content\/9781610020473\/9781610020473.","DOI":"10.1542\/9781610020473"},{"issue":"3","key":"825_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/archpedi.1969.02100040456007","volume":"118","author":"LI Kramer","year":"1969","unstructured":"Kramer LI. Advancement of dermal Icterus in the jaundiced newborn. Am J Dis Child. 1969;118(3):454\u20138. https:\/\/doi.org\/10.1001\/archpedi.1969.02100040456007.","journal-title":"Am J Dis Child"},{"key":"825_CR10","doi-asserted-by":"crossref","unstructured":"Madlon-Kay DJ. Recognition of the presence and severity of newborn jaundice by parents, nurses, physicians, and icterometer. Pediatrics. 1997;100(3). doi:10.1542\/peds.100.3.e3.","DOI":"10.1542\/peds.100.3.e3"},{"issue":"7","key":"825_CR11","doi-asserted-by":"publisher","first-page":"132270","DOI":"10.1371\/journal.pone.0132270","volume":"10","author":"A Franciscovich","year":"2015","unstructured":"Franciscovich A, Vaidya D, Doyle J, et al. Poop MD, a mobile health application, accurately identifies infant acholic stools. PLoS One. 2015;10(7):132270. https:\/\/doi.org\/10.1371\/journal.pone.0132270.","journal-title":"PLoS One"},{"key":"825_CR12","doi-asserted-by":"publisher","unstructured":"Gu YH, Yokoyama K, Mizuta K, et al. Stool color card screening for early detection of biliary atresia and long-term native liver survival: a 19-year cohort study in Japan. J Pediatr. 2015;166(4):897-902.e1. Doi:https:\/\/doi.org\/10.1016\/j.jpeds.2014.12.063. Piviotal article discussing the results of the first stool color card program which was established in 1994 in Tochigi prefecture, Japan.","DOI":"10.1016\/j.jpeds.2014.12.063"},{"issue":"6","key":"825_CR13","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1053\/jpsu.2001.23965","volume":"36","author":"ER Howard","year":"2001","unstructured":"Howard ER, MacLean G, Nio M, Donaldson N, Singer J, Ohi R. Survival patterns in biliary atresia and comparison of quality of life of long-term survivors in Japan and England. J Pediatr Surg. 2001;36(6):892\u20137. https:\/\/doi.org\/10.1053\/jpsu.2001.23965.","journal-title":"J Pediatr Surg"},{"key":"825_CR14","doi-asserted-by":"publisher","unstructured":"Chen SM, Chang MH, Du JC, et al. Screening for biliary atresia by infant stool color card in Taiwan. Pediatrics. 2006;117(4):1147-1154. https:\/\/doi.org\/10.1542\/peds.2005-1267. Taiwan implemented the first ever national biliary atresia screening program.","DOI":"10.1542\/peds.2005-1267"},{"key":"825_CR15","doi-asserted-by":"publisher","unstructured":"Lee M, Chen SCC, Yang HY, Huang JH, Yeung CY, Lee HC. Infant stool color card screening helps reduce the hospitalization rate and mortality of biliary atresia a 14-year nationwide cohort study in Taiwan. Med (United States). 2016;95(12). https:\/\/doi.org\/10.1097\/MD.0000000000003166.","DOI":"10.1097\/MD.0000000000003166"},{"issue":"1","key":"825_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/hep.24023","volume":"53","author":"TH Lien","year":"2011","unstructured":"Lien TH, Chang MH, Wu JF, et al. Effects of the infant stool color card screening program on 5-year outcome of biliary atresia in Taiwan. Hepatology. 2011;53(1):202\u20138. https:\/\/doi.org\/10.1002\/hep.24023.","journal-title":"Hepatology."},{"issue":"11","key":"825_CR17","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00383-019-04526-w","volume":"35","author":"O Madadi-Sanjani","year":"2019","unstructured":"Madadi-Sanjani O, Blaser J, Voigt G, Kuebler JF, Petersen C. Home-based color card screening for biliary atresia: the first steps for implementation of a nationwide newborn screening in Germany. Pediatr Surg Int. 2019;35(11):1217\u201322. https:\/\/doi.org\/10.1007\/s00383-019-04526-w.","journal-title":"Pediatr Surg Int"},{"issue":"6","key":"825_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/MPG.0000000000001950","volume":"66","author":"JP Woolfson","year":"2018","unstructured":"Woolfson JP, Schreiber RA, Butler AE, et al. Province-wide biliary atresia home screening program in British Columbia: evaluation of first 2 years. J Pediatr Gastroenterol Nutr. 2018;66(6):845\u20139. https:\/\/doi.org\/10.1097\/MPG.0000000000001950.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"825_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/bmjpo-2018-000269","volume":"2","author":"M Borgeat","year":"2018","unstructured":"Borgeat M, Korff S, Wildhaber BE. Newborn biliary atresia screening with the stool colour card: a questionnaire survey of parents. BMJ Paediatr Open. 2018;2(1):269. https:\/\/doi.org\/10.1136\/bmjpo-2018-000269.","journal-title":"BMJ Paediatr Open"},{"issue":"6","key":"825_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2223\/JPED.2057","volume":"86","author":"JA Bezerra","year":"2010","unstructured":"Bezerra JA. Biliary atresia in Brazil: where we are and where we are going. J Pediatr. 2010;86(6):445\u20137. https:\/\/doi.org\/10.2223\/JPED.2057.","journal-title":"J Pediatr"},{"key":"825_CR21","doi-asserted-by":"crossref","unstructured":"COMMITTEE ON PRACTICE AND AMBULATORY MEDICINE BFPSW. 2021 recommendations for preventive pediatric health care. Pediatrics. 2021;147(3). doi:10.1542\/PEDS.2020-049776.","DOI":"10.1542\/peds.2020-049776"},{"key":"825_CR22","doi-asserted-by":"publisher","unstructured":"Harpavat S, Finegold MJ, Karpen SJ. Patients with biliary atresia have elevated direct\/conjugated bilirubin levels shortly after birth. Pediatrics. 2011;128(6).https:\/\/doi.org\/10.1542\/peds.2011-1869.","DOI":"10.1542\/peds.2011-1869"},{"key":"825_CR23","doi-asserted-by":"publisher","unstructured":"Keffler S, Kelly DA, Powell JE, Green A. Population screening for neonatal liver disease: a feasibility study. J Pediatr Gastroenterol Nutr. 1998;27(3):306-311. https:\/\/doi.org\/10.1097\/00005176-199809000-00007. This was one of the earliest studies that screened all infants for liver disease with fractionated bilirubin.","DOI":"10.1097\/00005176-199809000-00007"},{"issue":"3","key":"825_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/096914130301000303","volume":"10","author":"JE Powell","year":"2003","unstructured":"Powell JE, Keffler S, Kelly DA, Green A. Population screening for neonatal liver disease: potential for a community-based Programme. J Med Screen. 2003;10(3):112\u20136. https:\/\/doi.org\/10.1177\/096914130301000303.","journal-title":"J Med Screen"},{"issue":"6","key":"825_CR25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/nejmc1601230","volume":"375","author":"S Harpavat","year":"2016","unstructured":"Harpavat S, Garcia-Prats JA, Shneider BL. Newborn bilirubin screening for biliary atresia. N Engl J Med. 2016;375(6):605\u20136. https:\/\/doi.org\/10.1056\/nejmc1601230.","journal-title":"N Engl J Med"},{"key":"825_CR26","doi-asserted-by":"publisher","unstructured":"Harpavat S, Garcia-Prats JA, Anaya C, et al. Diagnostic yield of newborn screening for biliary atresia using direct or conjugated bilirubin measurements. JAMA - J am med Assoc. 2020;323(12):1141-1150.https:\/\/doi.org\/10.1001\/jama.2020.0837. Results from this study showed that measuring fractionated bilirubin is a viable method to screen for biliary atresia in the newborn period.","DOI":"10.1001\/jama.2020.0837"},{"key":"825_CR27","doi-asserted-by":"publisher","unstructured":"Masucci L, Schreiber RA, Kaczorowski J, Collet JP, Bryan S. Universal screening of newborns for biliary atresia: cost-effectiveness of alternative strategies. J med screen. 2019;26(3). https:\/\/doi.org\/10.1177\/0969141319832039. Study showing that implementing the stool color card has acceptable cost-effectiveness.","DOI":"10.1177\/0969141319832039"},{"issue":"7208","key":"825_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1136\/bmj.319.7208.471","volume":"319","author":"I Mushtaq","year":"1999","unstructured":"Mushtaq I, Logan S, Morris M, et al. Screening of newborn infants for cholestatic hepatobiliary disease with tandem mass spectrometry. Br Med J. 1999;319(7208):471\u20137. https:\/\/doi.org\/10.1136\/bmj.319.7208.471.","journal-title":"Br Med J"},{"issue":"11","key":"825_CR29","doi-asserted-by":"publisher","first-page":"49270","DOI":"10.1371\/journal.pone.0049270","volume":"7","author":"K Zhou","year":"2012","unstructured":"Zhou K, Lin N, Xiao Y, et al. Elevated bile acids in newborns with biliary atresia (BA). PLoS One. 2012;7(11):49270. https:\/\/doi.org\/10.1371\/journal.pone.0049270.","journal-title":"PLoS One"},{"issue":"4","key":"825_CR30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jpeds.2010.09.061","volume":"158","author":"AR Davis","year":"2011","unstructured":"Davis AR, Rosenthal P, Escobar GJ, Newman TB. Interpreting conjugated bilirubin levels in newborns. J Pediatr. 2011;158(4):562. https:\/\/doi.org\/10.1016\/j.jpeds.2010.09.061.","journal-title":"J Pediatr"},{"issue":"3","key":"825_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1053\/j.semperi.2011.02.008","volume":"35","author":"SF Lo","year":"2011","unstructured":"Lo SF, Doumas BT. The status of bilirubin measurements in U.S. laboratories: why is accuracy elusive? Semin Perinatol. 2011;35(3):141\u20137. https:\/\/doi.org\/10.1053\/j.semperi.2011.02.008.","journal-title":"Semin Perinatol"},{"key":"825_CR32","doi-asserted-by":"crossref","unstructured":"Ozarda Y. Reference intervals: Current status, recent developments and future considerations. Biochem Medica. 2016;26(1):5\u201316. doi:10.11613\/BM.2016.001.","DOI":"10.11613\/BM.2016.001"},{"issue":"February","key":"825_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.plabm.2021.e00232","volume":"25","author":"CKM Ho","year":"2021","unstructured":"Ho CKM, Chen C, Setoh JWS, Yap WWT, Hawkins RCW. Optimization of hemolysis, icterus and lipemia interference thresholds for 35 clinical chemistry assays: interference of chemistry assays by hemolysis, icterus and lipemia. Pract Lab Med. 2021;25(February):e00232. https:\/\/doi.org\/10.1016\/j.plabm.2021.e00232.","journal-title":"Pract Lab Med"},{"key":"825_CR34","unstructured":"CLSI. NBS01-A6 DVD: Making a Difference by Newborn Screening.; 2014. Accessed July 6, 2021. https:\/\/clsi.org\/standards\/products\/newborn-screening\/companion\/nbs01a6dvd\/."},{"issue":"1","key":"825_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/MPG.0000000000001334","volume":"64","author":"R Fawaz","year":"2017","unstructured":"Fawaz R, Baumann U, Ekong U, et al. Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the north American society for pediatric gastroenterology, hepatology, and nutrition and the European society for pediatric gastroenterology, hepatology, and nutriti. J Pediatr Gastroenterol Nutr. 2017;64(1):154\u201368. https:\/\/doi.org\/10.1097\/MPG.0000000000001334.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"825_CR36","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jpedsurg.2014.08.014","volume":"50","author":"T Jancelewicz","year":"2015","unstructured":"Jancelewicz T, Barmherzig R, Chung CTS, et al. A screening algorithm for the efficient exclusion of biliary atresia in infants with cholestatic jaundice. J Pediatr Surg. 2015;50(3):363\u201370. https:\/\/doi.org\/10.1016\/j.jpedsurg.2014.08.014.","journal-title":"J Pediatr Surg"},{"issue":"3","key":"825_CR37","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1399-3046.2004.00153.x","volume":"8","author":"SV McDiarmid","year":"2004","unstructured":"McDiarmid SV, Anand R, Lindblad AS. Studies of pediatric liver transplantation: 2002 update. An overview of demographics, indications, timing, and immunosuppressive practices in pediatric liver transplantation in the United States and Canada. Pediatr Transplant. 2004;8(3):284\u201394. https:\/\/doi.org\/10.1111\/j.1399-3046.2004.00153.x.","journal-title":"Pediatr Transplant"},{"key":"825_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2012\/132089","volume":"2012","author":"BE Wildhaber","year":"2012","unstructured":"Wildhaber BE. Biliary atresia: 50 years after the first Kasai. ISRN Surg. 2012;2012:1\u201315. https:\/\/doi.org\/10.5402\/2012\/132089.","journal-title":"ISRN Surg"},{"issue":"4","key":"825_CR39","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/MPG.0000000000002450","volume":"69","author":"KR Mysore","year":"2019","unstructured":"Mysore KR, Shneider BL, Harpavat S. Biliary atresia as a disease starting in utero: implications for treatment, diagnosis, and pathogenesis. J Pediatr Gastroenterol Nutr. 2019;69(4):396\u2013403. https:\/\/doi.org\/10.1097\/MPG.0000000000002450.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"825_CR40","doi-asserted-by":"publisher","first-page":"392","DOI":"10.4254\/wjh.v7.i3.392","volume":"7","author":"RB Pinto","year":"2015","unstructured":"Pinto RB, Schneider ACR, da Silveira TR. Cirrhosis in children and adolescents: an overview. World J Hepatol. 2015;7(3):392\u2013405. https:\/\/doi.org\/10.4254\/wjh.v7.i3.392.","journal-title":"World J Hepatol"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-021-00825-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-021-00825-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-021-00825-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T18:34:05Z","timestamp":1640889245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-021-00825-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["825"],"URL":"https:\/\/doi.org\/10.1007\/s11894-021-00825-2","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,24]]},"assertion":[{"value":"24 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SH is on a Data Safety Monitoring Board coordinated by Syneos Health, for a clinical trial that tests a therapy for biliary atresia.Code availability: Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}}],"article-number":"28"}}